.png)


The best choice for early-stage ADME, tox, and DMPK workflows.
Lucero’s Thaw-N-Dose plates enable early-stage screening teams to test metabolic activity, toxicity, and understand mechanisms of action in 3D — no culturing required.
Built for rigorous and iterative DMTA testing cycles to generate patient-relevant data that enables more confident go/no-decision decisions.
We want drug developers to be able to screen each and every compound using patient-relevant 3D models at a cost they can afford without jeopardizing critical project timelines.
That’s why we built Lucero.
To turn a frustrating, delicate, and manually-intensive process into a plug-and-play consumable that can be used by anyone.
Lucero’s platform enables us to miniaturize our models to extend the value of precious and limited donor material.
We’re opening our early pilot testing to new users in Q126.
We’re looking for cutting-edge scientists who: